HBW Advisory Services’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87M Buy
23,907
+850
+4% +$68.6K 0.17% 129
2026
Q1
$2M Buy
23,057
+1,293
+6% +$124K 0.21% 112
2025
Q4
$2.09M Sell
21,764
-10,819
-33% -$1.05M 0.23% 104
2025
Q3
$3.1M Sell
32,583
-1,103
-3% -$101K 0.35% 70
2025
Q2
$2.94M Sell
33,686
-2,179
-6% -$185K 0.36% 65
2025
Q1
$3.22M Buy
35,865
+1,581
+5% +$141K 0.46% 52
2024
Q4
$2.74M Buy
34,284
+299
+0.9% +$25.9K 0.28% 65
2024
Q3
$3.06M Buy
33,985
+530
+2% +$44.6K 0.45% 57
2024
Q2
$2.63M Buy
33,455
+6,229
+23% +$511K 0.44% 72
2024
Q1
$2.24M Hold
27,226
0.42% 71
2023
Q4
$2.24M Buy
27,226
+1,576
+6% +$120K 0.42% 71
2023
Q3
$2.01M Buy
25,650
+12,490
+95% +$1.05M 0.42% 72
2023
Q2
$1.16M Buy
13,160
+1,526
+13% +$131K 0.25% 97
2023
Q1
$937K Buy
+11,634
New +$948K 0.23% 110

Other funds holding MDT

HBW Advisory Services's MDT Position: Q2 2026 in Review

HBW Advisory Services increased its Medtronic (MDT) stake by 3.7% in Q2 2026, buying an estimated $68.6K and bringing the position to 23,907 shares worth $1.87M. The position accounts for 0.17% of the portfolio, ranked #129.

HBW Advisory Services first reported a position in MDT in Q1 2023 and has held it in 14 quarters since. The position peaked at $3.22M in Q1 2025. 2,125 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • HBW Advisory Services held 23,907 shares of Medtronic worth $1.87M as of Q2 2026.
  • HBW Advisory Services bought 850 Medtronic shares in Q2 2026, an estimated $68.6K.
  • Medtronic made up 0.17% of HBW Advisory Services's portfolio in Q2 2026, its #129 holding.
  • HBW Advisory Services first reported a position in Medtronic in Q1 2023 and has held it in 14 quarters since.
  • HBW Advisory Services's Medtronic position peaked at $3.22M in Q1 2025.
  • 2,125 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.